What is the recommended dosage for Flonase (fluticasone propionate) for allergic rhinitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flonase (Fluticasone Propionate) Dosing for Allergic Rhinitis

For adults and adolescents ≥12 years, start with 2 sprays per nostril once daily (200 mcg total), administered in the morning; for children 4-11 years, use 1 spray per nostril once daily (100 mcg total). 1

Adult and Adolescent Dosing (≥12 years)

The standard starting dose is 200 mcg once daily, delivered as 2 sprays (50 mcg each) per nostril in the morning. 1 This can alternatively be divided into 100 mcg twice daily (1 spray per nostril twice daily), though clinical trials showed no significant differences between once-daily and twice-daily regimens. 1

  • After 4-7 days of treatment, patients who have responded may be maintained on a reduced dose of 100 mcg daily (1 spray per nostril once daily). 1
  • Maximum daily dose should not exceed 200 mcg (2 sprays per nostril); exceeding this dose has not been shown to provide additional benefit. 1
  • Onset of symptom relief occurs as early as 12 hours after the first dose, but maximal efficacy requires several days to weeks of regular use. 1, 2

Pediatric Dosing (4-11 years)

Children should start with 100 mcg once daily (1 spray per nostril). 1 The 200 mcg dose (2 sprays per nostril once daily or 1 spray twice daily) should be reserved only for children not adequately responding to 100 mcg daily. 1

  • Once adequate control is achieved, decrease back to 100 mcg daily. 1
  • Clinical trials in children as young as 4 years demonstrated that 100 mcg once daily is as effective as the 200 mcg adult dose for seasonal allergic rhinitis. 3
  • Fluticasone propionate is FDA-approved for children ≥4 years of age. 4

Administration Technique

Proper spray technique is critical to minimize side effects, particularly epistaxis. 4, 2

  • Use the contralateral hand technique (right hand for left nostril, left hand for right nostril) to naturally direct the spray away from the nasal septum—this reduces epistaxis risk by four-fold. 4, 2
  • Prime the bottle before first use and shake before each administration. 4
  • Have the patient blow their nose prior to spraying. 4
  • Keep the head upright during administration and breathe in gently during spraying. 4
  • Do not close the opposite nostril during administration. 4
  • If using nasal saline irrigations, perform them before administering fluticasone to avoid rinsing out the medication. 4, 2

Duration of Treatment

Fluticasone should be used at regular intervals as maintenance therapy, not as-needed rescue therapy. 1 Long-term use is both safe and effective, with studies demonstrating safety for up to 52 weeks of continuous use. 4

  • For seasonal allergic rhinitis, initiate treatment before symptom onset and continue throughout the allergen exposure period. 4
  • Minimum treatment duration should be 8-12 weeks to properly assess therapeutic benefit. 4
  • Patients must be counseled to continue therapy for at least 2 weeks after initiation, as full benefit may not be evident during this early period. 4
  • Unlike topical decongestants (which cause rebound congestion after 3 days), intranasal corticosteroids do not cause rhinitis medicamentosa and are safe for long-term daily use. 4

Safety Considerations

Common side effects include headache, pharyngitis, epistaxis, nasal burning/irritation, nausea, and cough, all generally mild to moderate. 4, 2

  • Fluticasone propionate, mometasone furoate, and budesonide show no effect on growth at recommended doses in children, even at up to twice the recommended doses. 4
  • Studies have failed to demonstrate clinically relevant effects on the hypothalamic-pituitary-adrenal axis in children and adults at recommended doses. 4, 3
  • Long-term use does not affect systemic cortisol levels or increase risk of lens opacity, elevated intraocular pressure, or glaucoma. 4
  • Periodically examine the nasal septum during long-term use to detect mucosal erosions that may precede septal perforation (a rare complication). 4

When Initial Treatment Fails

If symptoms persist after 2 weeks of fluticasone monotherapy, add intranasal azelastine (an intranasal antihistamine). 2 The combination of fluticasone propionate and azelastine provides more than 40% greater symptom reduction than either agent alone. 4, 2

  • If no improvement occurs after 3 months of intranasal corticosteroid therapy, consider a short course of oral corticosteroids or proceed to CT imaging and surgical evaluation. 4
  • Oral antihistamines are less effective than intranasal corticosteroids for nasal congestion, though they may help with sneezing and itching. 4
  • Leukotriene receptor antagonists are not recommended as primary therapy, as they are significantly less effective than intranasal corticosteroids. 4

Contraindications

Fluticasone is contraindicated in patients with hypersensitivity to fluticasone or any component of the formulation. 4, 2

References

Guideline

Fluticasone Dosing Strategy for Allergic Rhinitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Intranasal Steroid Recommendations for Allergic Rhinitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.